Company / Operating Income per Share
RIGEL PHARMACEUTICALS INC Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$7.08
FY2025
5-year range
-$0.32 / $7.08
FY2021-FY2025
Trend
+412.0%
vs FY2024
Sector context
#10 of 201
Health Care
What the data says
Operating Income per Share changed +412% YoY in FY2025, a notable deviation from the 9-year average annual change of +175%.
Based on SEC 10-K filings.
7.08 in FY2025. Top quartile in the Health Care sector.
Improved from $-0.12 to $7.08 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 201This company $7.08 Sector average -$3.23
▼
+319.1% above sector average
Key checks
Key Insights
- RIGEL PHARMACEUTICALS INC's operating income per share has grown for 3 consecutive years.
- In FY2025, operating income per share increased 412.0% year-over-year.
- Ranks #10 out of 201 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.08 | +412.0% |
| FY2024 | $1.38 | +1271.0% |
| FY2023 | -$0.12 | +63.5% |
| FY2022 | -$0.32 | -338.6% |
| FY2021 | -$0.07 | +57.2% |
| FY2020 | -$0.17 | +58.3% |
| FY2019 | -$0.41 | +13.0% |
| FY2018 | -$0.48 | +24.6% |
| FY2017 | -$0.63 | +14.7% |
| FY2016 | -$0.74 | -26.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026